Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
2.940
-0.070 (-2.33%)
At close: Jul 18, 2025, 4:00 PM
2.999
+0.059 (1.99%)
After-hours: Jul 18, 2025, 6:46 PM EDT

Clover Health Investments Stock Forecast

Stock Price Forecast

The 3 analysts that cover Clover Health Investments stock have a consensus rating of "Strong Buy" and an average price target of $4.83, which forecasts a 64.29% increase in the stock price over the next year. The lowest target is $4 and the highest is $6.

Price Target: $4.83 (+64.29%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$4.00$4.83$4.50$6.00
Change+36.05%+64.29%+53.06%+104.08%
* Price targets were last updated on Mar 3, 2025.

Analyst Ratings

The average analyst rating for Clover Health Investments stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy122222
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total233333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$4.2$4.5
Strong BuyMaintains$4.2$4.5+53.06%Mar 3, 2025
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$6
Strong BuyInitiates$6+104.08%Dec 17, 2024
UBS
UBS
Hold
Initiates
$4
HoldInitiates$4+36.05%Oct 7, 2024
Citigroup
Citigroup
Hold
Maintains
$1$1.5
HoldMaintains$1$1.5-48.98%Aug 11, 2023
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$4$3
Strong BuyMaintains$4$3+2.04%Mar 6, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
1.90B
from 1.37B
Increased by 38.62%
Revenue Next Year
2.32B
from 1.90B
Increased by 22.21%
EPS This Year
-0.13
from -0.09
EPS Next Year
-0.13
from -0.13
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
690.02M1.36B1.20B1.26B1.37B1.90B2.32B2.50B
Revenue Growth
51.74%97.30%-11.91%5.32%8.52%38.62%22.21%7.75%
EPS
-1.54-1.42-0.71-0.44-0.09-0.13-0.13-0.01
EPS Growth
--------
Forward PE
--------
No. Analysts
-----664
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High2.0B2.5B2.7B
Avg1.9B2.3B2.5B
Low1.8B2.1B2.2B

Revenue Growth

Revenue Growth20252026202720282029
High
44.6%
30.1%
17.1%
Avg
38.6%
22.2%
7.8%
Low
31.3%
9.6%
-5.8%

EPS Forecast

EPS20252026202720282029
High-0.11-0.110.04
Avg-0.13-0.13-0.01
Low-0.16-0.15-0.05

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.